Divis Lab hits record high after consolidated Q4 profit rises 29% yoy to Rs502cr
The Pharma company earns revenue of Rs7032cr for FY21 on a consolidated basis.
from India Infoline News Service https://ift.tt/3fyhHEM
from India Infoline News Service https://ift.tt/3fyhHEM
Comments